Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Purely mathematical perspective on delaying the second dose of the SARS-CoV-2 vaccine

High demand for the vaccines has raised questions as to whether it would be better in the long term to ensure that as much of the population as possible has received the first dose, i.e., vaccinate twice as many people with a lower rate of efficacy.

17 Feb 2021

Study uncovers how the SARS-CoV-2 B.1.1.7 variant entered the United States

A team led by researchers from the Yale School of Public Health has found how the B.1.1.7 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first found in the United Kingdom, made its way into several states in the United States.

17 Feb 2021

New N501Y SARS-CoV-2 mutations increase binding to host cell receptor

A team of researchers used several assays, atomic force microscopy, and simulations to determine that the N501Y mutation in the virus’s receptor-binding domain (RBD) increased the interaction of the virus with the angiotensin-converting enzyme 2 (ACE2) receptor.

17 Feb 2021

SARS-CoV-2 nucleoprotein increases infectivity of spike-based pseudoviruses

In a recent study conducted at the Indian Institute of Science Education and Research, India, a team of scientists screened specific genes of SARS-CoV-2 to identify factors that may contribute to viral infectivity.

17 Feb 2021

Bats and pangolins in Southeast Asia harbor SARS-CoV-2-related coronaviruses, study finds

A new study has reported evidence that SARS-CoV-2-related coronaviruses (SC2r-CoVs) are circulating in bats in Southeast Asia. This has extended the geographical area where SC2r-CoVs are found, underscoring the urgency of identifying the immediate ancestor of SARS-CoV-2.

17 Feb 2021

The origin of SARS-CoV-2 furin cleavage site remains a mystery

A new study discusses the origin of the furin cleavage site on the SARS-CoV-2 spike protein, which is responsible for the virus’s relatively high infectivity compared to relatives in the betacoronavirus subgenus.

17 Feb 2021

What are the main food safety concerns associated with the COVID-19 pandemic?

A new study deals with the main food safety concerns associated with the COVID-19 pandemic.

17 Feb 2021

China's SARS and SARS-CoV-2 outbreak management in comparative perspective

A new study compares the current SARS-CoV-2 outbreak with the earlier SARS-CoV epidemic to understand the best way to respond to it sensitively and flexibly. This involves early detection, using multiple screening tests, followed by management of the clinical features as required, in order to prevent disease-related injury.

17 Feb 2021

Probiotics may be beneficial in COVID-19 treatment

A new study explores the role of common probiotics in managing the disease, which could prove to be of great value, given the emergence of new variants and the broad spectrum of clinical disease in COVID-19.

17 Feb 2021

Humidity created inside facemasks may help combat COVID-19, study finds

A new study, published in the journal Biophysical Journal by researchers at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), showed that face masks increase the humidity in the air that the mask-wearers inhale. The level of moisture in inhaled air could be linked to lower levels of COVID-19 severity.

16 Feb 2021

Pan-coronavirus vaccine needed to deal SARS-CoV-2 variants

In an article, published on the JAMA Network and written by health experts, including Dr. Anthony Fauci, American physician-scientist and immunologist serving as the director of the National Institute of Allergy and Infectious Diseases, the authors discuss the need for a pan-coronavirus vaccine, which can protect against most or all variants of SARS-CoV-2.

16 Feb 2021

Virus transmission by dental tools and prevention by antiviral agent

Researchers at the University of Ljubljana have demonstrated how a virus can spread by droplets during ultrasonic scaler (USS) operation and how this spread can be mitigated by merely substituting the irrigant with clinical virucidal agents, namely sodium hypochlorite and EOW (Electrolyzed Oxidizing Water).

16 Feb 2021

Stability and pathogenicity of MERS coronavirus varies across different viral strains

An international team of researchers has conducted a study suggesting that individual variation across different strains of betacoronaviruses can alter their stability and pathogenicity profiles.

16 Feb 2021

A pangolin coronavirus spike glycoprotein sheds light on SARS-CoV-2’s evolution

As the exact zoonotic origin of SARS-CoV-2 remains unresolved, scientists at the Francis Crick Institute in London, UK, explored the structure and binding properties of a Pangolin coronavirus spike glycoprotein to see if it could shed light on the evolution of SARS-CoV-2.

16 Feb 2021

UV light can be used to disinfect SARS-CoV-2 contaminated surfaces, says study

Using different UV exposure times and dosages, researchers showed that surfaces like glass, plastic, stainless steel, and N95 respirator material could be quickly and easily disinfected.

16 Feb 2021

Artemisia plant extracts show potential anti-SARS-CoV-2 activity in vitro

A team of scientists from Germany and the USA recently explored the effectiveness of traditional plant medicines in treating SARS-CoV-2 infection.

16 Feb 2021

What are the changes in the physical phenotype of blood cells in COVID-19?

While primarily a respiratory illness, there are distinctive alterations in the type and number of blood cells in COVID-19. A new study by a team of researchers in Germany describes the nature of these changes.

16 Feb 2021

British and South African SARS-CoV-2 variants show some resistance to neutralizing antibodies

Researchers in France report impaired neutralization of two new SARS-CoV-2 variants by antibodies induced by vaccination or natural infection.

16 Feb 2021

Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies

A new preprint research paper posted to the bioRxiv server provides a greater understanding of the aspect of humoral immunity against the virus – the plasma cells that pour out a flood of specific antibodies targeting various epitopes on the pathogen.

16 Feb 2021

Mink-derived SARS-CoV-2 mutations reduce antibody effectiveness

A new preprint research paper posted to the bioRxiv* server shows that these mutations disrupt inhibition by neutralizing antibodies, both natural and therapeutic.

16 Feb 2021